BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 8698242)

  • 21. The Brca1 and Brca2 proteins and tumor pathogenesis.
    Ingvarsson S
    Anticancer Res; 1999; 19(4B):2853-61. PubMed ID: 10652564
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Notch1 is essential for postimplantation development in mice.
    Swiatek PJ; Lindsell CE; del Amo FF; Weinmaster G; Gridley T
    Genes Dev; 1994 Mar; 8(6):707-19. PubMed ID: 7926761
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Arginine N-methyltransferase 1 is required for early postimplantation mouse development, but cells deficient in the enzyme are viable.
    Pawlak MR; Scherer CA; Chen J; Roshon MJ; Ruley HE
    Mol Cell Biol; 2000 Jul; 20(13):4859-69. PubMed ID: 10848611
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Loss of heterozygosity in familial tumors from three BRCA1-linked kindreds.
    Neuhausen SL; Marshall CJ
    Cancer Res; 1994 Dec; 54(23):6069-72. PubMed ID: 7954448
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antisense RNA to the putative tumor suppressor gene BRCA1 transforms mouse fibroblasts.
    Rao VN; Shao N; Ahmad M; Reddy ES
    Oncogene; 1996 Feb; 12(3):523-8. PubMed ID: 8637708
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Requirement for the murine zinc finger protein ZFR in perigastrulation growth and survival.
    Meagher MJ; Braun RE
    Mol Cell Biol; 2001 Apr; 21(8):2880-90. PubMed ID: 11283266
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Requirement for tumor suppressor Apc in the morphogenesis of anterior and ventral mouse embryo.
    Ishikawa TO; Tamai Y; Li Q; Oshima M; Taketo MM
    Dev Biol; 2003 Jan; 253(2):230-46. PubMed ID: 12645927
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A murine homolog of the yeast RNA1 gene is required for postimplantation development.
    DeGregori J; Russ A; von Melchner H; Rayburn H; Priyaranjan P; Jenkins NA; Copeland NG; Ruley HE
    Genes Dev; 1994 Feb; 8(3):265-76. PubMed ID: 8314081
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The bZIP transcription factor LCR-F1 is essential for mesoderm formation in mouse development.
    Farmer SC; Sun CW; Winnier GE; Hogan BL; Townes TM
    Genes Dev; 1997 Mar; 11(6):786-98. PubMed ID: 9087432
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bone morphogenetic protein-4 is required for mesoderm formation and patterning in the mouse.
    Winnier G; Blessing M; Labosky PA; Hogan BL
    Genes Dev; 1995 Sep; 9(17):2105-16. PubMed ID: 7657163
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Early embryonic lethality caused by targeted disruption of the mouse thioredoxin gene.
    Matsui M; Oshima M; Oshima H; Takaku K; Maruyama T; Yodoi J; Taketo MM
    Dev Biol; 1996 Aug; 178(1):179-85. PubMed ID: 8812119
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Loss of N-myc function results in embryonic lethality and failure of the epithelial component of the embryo to develop.
    Stanton BR; Perkins AS; Tessarollo L; Sassoon DA; Parada LF
    Genes Dev; 1992 Dec; 6(12A):2235-47. PubMed ID: 1459449
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Targeted disruption of the mouse phospholipase C beta3 gene results in early embryonic lethality.
    Wang S; Gebre-Medhin S; Betsholtz C; Stålberg P; Zhou Y; Larsson C; Weber G; Feinstein R; Oberg K; Gobl A; Skogseid B
    FEBS Lett; 1998 Dec; 441(2):261-5. PubMed ID: 9883896
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inherited breast and ovarian cancer.
    Szabo CI; King MC
    Hum Mol Genet; 1995; 4 Spec No():1811-7. PubMed ID: 8541881
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Disruption of the HNF-4 gene, expressed in visceral endoderm, leads to cell death in embryonic ectoderm and impaired gastrulation of mouse embryos.
    Chen WS; Manova K; Weinstein DC; Duncan SA; Plump AS; Prezioso VR; Bachvarova RF; Darnell JE
    Genes Dev; 1994 Oct; 8(20):2466-77. PubMed ID: 7958910
    [TBL] [Abstract][Full Text] [Related]  

  • 36. BRCA1 deficient embryonic stem cells display a decreased homologous recombination frequency and an increased frequency of non-homologous recombination that is corrected by expression of a brca1 transgene.
    Snouwaert JN; Gowen LC; Latour AM; Mohn AR; Xiao A; DiBiase L; Koller BH
    Oncogene; 1999 Dec; 18(55):7900-7. PubMed ID: 10630642
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A high occurrence of BRCA1 and BRCA2 mutations among Czech hereditary breast and breast-ovarian cancer families.
    Machácková E; Foretová L; Navrátilová M; Valík D; Claes K; Messiaen L
    Cas Lek Cesk; 2000 Oct; 139(20):635-7. PubMed ID: 11192759
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A targeted mouse Brca1 mutation removing the last BRCT repeat results in apoptosis and embryonic lethality at the headfold stage.
    Hohenstein P; Kielman MF; Breukel C; Bennett LM; Wiseman R; Krimpenfort P; Cornelisse C; van Ommen GJ; Devilee P; Fodde R
    Oncogene; 2001 May; 20(20):2544-50. PubMed ID: 11420664
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mouse zinc transporter 1 gene provides an essential function during early embryonic development.
    Andrews GK; Wang H; Dey SK; Palmiter RD
    Genesis; 2004 Oct; 40(2):74-81. PubMed ID: 15452870
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Defective placental vasculogenesis causes embryonic lethality in VHL-deficient mice.
    Gnarra JR; Ward JM; Porter FD; Wagner JR; Devor DE; Grinberg A; Emmert-Buck MR; Westphal H; Klausner RD; Linehan WM
    Proc Natl Acad Sci U S A; 1997 Aug; 94(17):9102-7. PubMed ID: 9256442
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.